Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4053-4058, September 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Correction (v55,p5485)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamori, T.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamori, T.
Right arrow Articles by Mori, H.

Chemoprevention of Azoxymethane-induced Colon Carcinogenesis by Dietary Feeding of S-Methyl Methane Thiosulfonate in Male F344 Rats1

Toshihiko Kawamori, Takuji Tanaka2, Masami Ohnishi, Yoshinobu Hirose, Yasushi Nakamura, Kumiko Satoh, Akira Hara and Hideki Mori

First Department of Pathology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City 500 [T. K., T. T., M. O., Y. H., H. M.]; School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422 [Y. N.]; and Department of Biochemistry, Gifu Pharmaceutical University, 5-6-1, Mitahora Higashi, Gifu City 502 [K. S., A. H.], Japan

Modifying effects of dietary exposure of S-methyl methane thiosulfonate (MMTS) isolated from cauliflower Brassica oleracea L. var. botrytis on rat colon carcinogenesis induced by azoxymethane (AOM) and on the expression of cell proliferation biomarkers were investigated in two experiments. In experiment 1, male F344 rats were given three s.c. injections of AOM (15 mg/kg body weight) and fed 100 ppm MMTS for 5 weeks, starting 1 week before the first dose of AOM. The frequency of colonic aberrant crypt foci was determined at 5 weeks after the start. Feeding of 100 ppm MMTS for 5 weeks significantly decreased the number of aberrant crypt foci/colon. Colonic mucosal ornithine decarboxylase activity and the number of silver-stained nucleolar organizer regions per nucleus in colonic epithelium were significantly decreased by MMTS treatment compared with those of AOM alone. In experiment 2, effects of dietary feeding of MMTS at two doses (20 and 100 ppm) during the postinitiation phase on intestinal tumorigenesis initiated with AOM were investigated by using a long-term experiment in male F344 rats. Incidences of intestinal neoplasms of rats fed MMTS-containing diets after AOM exposure were reduced in a dose-dependent manner. Feeding of MMTS during the postinitiation phase decreased the number of aberrant crypt foci/colon, colonic ornithine decarboxylase activity, 5-bromodeoxyuridine-labeling index in colonic epithelium, and polyamine level in blood compared with those of AOM alone. These results suggest that MMTS might be a possible chemopreventive agent for intestinal neoplasia.

1 This work was supported by a grant from the Ministry of Health and Welfare, Japan.

2 To whom requests for reprints should be addressed.

Received 4/24/95. Accepted 7/19/95.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. Kitamura, T. Kawamori, N. Uchiya, M. Itoh, T. Noda, M. Matsuura, T. Sugimura, and K. Wakabayashi
Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis
Carcinogenesis, September 1, 2002; 23(9): 1463 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Yamada, N. Yoshimi, Y. Hirose, K. Matsunaga, M. Katayama, K. Sakata, M. Shimizu, T. Kuno, and H. Mori
Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis
Cancer Res., March 1, 2001; 61(5): 1874 - 1878.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. R. Bruce, A. Giacca, and A. Medline
Possible Mechanisms Relating Diet and Risk of Colon Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1271 - 1279.
[Abstract] [Full Text]


Home page
GutHome page
Y Kishimoto, N Takata, T Jinnai, T Morisawa, G Shiota, H Kawasaki, and J Hasegawa
Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane
Gut, December 1, 2000; 47(6): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Parnaud, S. Tache, G. Peiffer, and D. E. Corpet
Polyethylene-glycol Suppresses Colon Cancer and Causes Dose-dependent Regression of Azoxymethane-induced Aberrant Crypt Foci in Rats
Cancer Res., October 1, 1999; 59(20): 5143 - 5147.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. S. Reddy, T. Kawamori, R. Lubet, V. Steele, G. Kelloff, and C. V. Rao
Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis
Carcinogenesis, August 1, 1999; 20(8): 1645 - 1648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.